# Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers

> **NCT00785460** · PHASE3 · COMPLETED · sponsor: **Ruhr University of Bochum** · enrollment: 20 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Benfotiamine

## Key facts

- **NCT ID:** NCT00785460
- **Lead sponsor:** Ruhr University of Bochum
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-05
- **Final completion:** —
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2008-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00785460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00785460, "Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00785460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*